Common Contracts
12 similar Underwriting Agreement contracts by AMERI Holdings, Inc., Vislink Technologies, Inc., Gamida Cell Ltd., others
UNDERWRITING AGREEMENTUnderwriting Agreement • November 8th, 2024 • Heritage Distilling Holding Company, Inc. • Beverages • Florida
The undersigned, Heritage Distilling Holding Company, Inc., a company incorporated under the laws of Delaware (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries or affiliates of Heritage Distilling Holding Company, Inc., the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which Newbridge Securities Corporation is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.
●] Class A Ordinary Shares (or Pre-Funded Warrants to Purchase [●] Shares of Common Stock in Lieu Thereof) Warrants to Purchase [●] Common Shares NEW HORIZON AIRCRAFT LTD. UNDERWRITING AGREEMENTUnderwriting Agreement • June 24th, 2024 • New Horizon Aircraft Ltd. • Aircraft • New York
New Horizon Aircraft Ltd., a British Columbia corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to several underwriters named on Schedule I hereto (each, an “Underwriter” and collectively, the “Underwriters”) for which EF Hutton LLC is acting as representative (the “Representative”) (i) an aggregate of [●] authorized but unissued Shares (the “Firm Shares” of Class A Ordinary Shares, no par value per share, of the Company (the “Common Shares”) or pre-funded warrants (the “Pre-Funded Warrants”) to purchase Common Shares in lieu thereof at an exercise price of $0.00001 per share (the “Pre-Funded Warrant Shares”), and (ii) warrants (the “Firm Warrants”) to purchase up to an aggregate of [●] Common Shares (the “Firm Warrant Shares”). The Company also proposes to sell to the Underwriters, upon the terms and conditions set forth herein, up to an additional [●] Common Shares (the “Option Shares” and, together with the Firm Shares, the “
UNDERWRITING AGREEMENTUnderwriting Agreement • April 21st, 2023 • Gamida Cell Ltd. • Biological products, (no disgnostic substances) • New York
Gamida Cell Ltd., a corporation organized under the laws of the State of Israel (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell an aggregate of (i) 17,500,000 shares (the “Firm Shares”) of the Company’s ordinary shares with a nominal value of New Israeli Shekel (“NIS”) 0.01 per share (the “Ordinary Shares”) and (ii) warrants, substantially in the form of Annex A hereto, to purchase an aggregate of 17,500,000 Ordinary Shares, with an exercise price of $1.35 per share (the “Ordinary Warrants,” and together with the Firm Shares, the “Firm Securities”), to the several underwriters (collectively, the “Underwriters”) named in Schedule I to this agreement (this “Agreement”), for whom Piper Sandler & Co. is acting as a representative (the “Representative”). The Firm Shares to be outstanding after giving effect to the sale of the Ordinary Shares are referred to herein as the “Stock.” In addition, the Company has granted to the Underwriters an opti
UNDERWRITING AGREEMENTUnderwriting Agreement • April 19th, 2022 • Oncocyte Corp • In vitro & in vivo diagnostic substances • New York
The undersigned, OncoCyte Corporation, a company incorporated under the laws of California (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries or affiliates of OncoCyte Corporation, the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which BTIG, LLC is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.
EX-1.1 2 ex11to8k10211020_111717.htm 1,475,000 Shares 1,475,000 Warrants to Purchase Shares1 Ameri Holdings, Inc. Common Stock, par value $0.01 per share Warrants to purchase Common Stock UNDERWRITING AGREEMENT November 17, 2017 Northland Securities,...Underwriting Agreement • May 5th, 2020 • New York
UNDERWRITING AGREEMENT between TIZIANA LIFE SCIENCES PLC and THINKEQUITY, A DIVISION OF FORDHAM FINANCIAL MANAGEMENT, INC., as Representative of the Several Underwriters TIZIANA LIFE SCIENCES plc 3,333,333 American Depositary Shares Representing...Underwriting Agreement • March 13th, 2020 • Tiziana Life Sciences PLC • Pharmaceutical preparations • New York
Vislink Technologies, Inc. [●] Shares Common Stock ($0.00001 par value per share) and Pre-Funded Warrants to Purchase up to [●] Shares of Common Stock and Warrants to Purchase up to [●] Shares of Common Stock Underwriting AgreementUnderwriting Agreement • October 30th, 2019 • Vislink Technologies, Inc. • Communications equipment, nec • New York
Vislink Technologies, Inc., a corporation organized under the laws of Delaware (including any predecessor entities, the “Company”), proposes to sell to the several underwriters named in Schedule I hereto (the “Underwriters”), for whom you (the “Representative”) are acting as Representative, (i) an aggregate of [●] shares of common stock, par value $0.00001 per share (“Common Stock”), of the Company (said shares to be issued and sold by the Company being hereinafter called the “Firm Shares”), (ii) pre-funded warrants to purchase up to an aggregate of [●] shares of Common Stock (the “Pre-Funded Warrants”) at an exercise price of $0.001 per share and (iii) warrants of the Company to purchase up to an aggregate of [●] shares of Common Stock (the “Firm Common Warrants”) at an exercise price equal to $[●] per share. The Firm Shares, Pre-Funded Warrants, and the Firm Common Warrants to be sold by the Company are collectively referred to as the “Firm Securities.” The Company also proposes to g
Vislink Technologies, Inc. 1,550,000 Shares Common Stock ($0.00001 par value per share) and Pre-Funded Warrants to Purchase up to 4,450,000 Shares of Common Stock and Warrants to Purchase up to 6,000,000 Shares of Common Stock Underwriting AgreementUnderwriting Agreement • July 16th, 2019 • Vislink Technologies, Inc. • Communications equipment, nec • New York
Vislink Technologies, Inc. [●] Shares Common Stock ($0.00001 par value per share) and Pre-Funded Warrants to Purchase up to [●] Shares of Common Stock and Warrants to Purchase up to [●] Shares of Common Stock Underwriting AgreementUnderwriting Agreement • July 10th, 2019 • Vislink Technologies, Inc. • Communications equipment, nec • New York
Vislink Technologies, Inc., a corporation organized under the laws of Delaware (including any predecessor entities, the “Company”), proposes to sell to the several underwriters named in Schedule I hereto (the “Underwriters”), for whom you (the “Representative”) are acting as Representative, (i) an aggregate of [●] shares of common stock, par value $0.00001 per share (“Common Stock”), of the Company (said shares to be issued and sold by the Company being hereinafter called the “Firm Shares”), (ii) pre-funded warrants to purchase up to an aggregate of [●] shares of Common Stock (the “Pre-Funded Warrants”) at an exercise price of $[●] per share and (iii) warrants of the Company to purchase up to an aggregate of [●] shares of Common Stock (the “Firm Common Warrants”) at an exercise price equal to $[●] per share. The Firm Shares, Pre-Funded Warrants, and the Firm Common Warrants to be sold by the Company are collectively referred to as the “Firm Securities.” The Company also proposes to gra
1,475,000 Shares 1,475,000 Warrants to Purchase Shares1 Ameri Holdings, Inc. Common Stock, par value $0.01 per share Warrants to purchase Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • November 17th, 2017 • AMERI Holdings, Inc. • Semiconductors & related devices • New York
Ameri Holdings, Inc., a Delaware corporation (the “Company”), proposes to sell to the Underwriters named in Schedule IV hereto (“Underwriters”) for whom Northland Securities, Inc. is acting as representative (the “Representative”) an aggregate of 1,475,000 shares (the “Firm Shares”) of Common Stock, par value $0.01 per share (the “Common Stock”), of the Company, together with warrants to purchase up to an aggregate of 1,475,000 shares of Common Stock (“Firm Warrants” and together with the Firm Shares, the “Firm Securities”) which shall have an exercise price of $4.115, subject to adjustment as provided in the Warrant Agent Agreement in substantially the form annexed hereto as Exhibit C (the “Warrant Agent Agreement”). The Firm Shares and Option Shares consist of authorized but unissued shares of Common Stock to be issued and sold by the Company. The Company also has granted to the Underwriters an option to purchase up to (a) an additional 15% of the total number of shares of Common Sto
FORM OF UNDERWRITING AGREEMENT [ Ÿ ] Shares [ Ÿ ] Warrants to Purchase Shares1 Ameri Holdings, Inc. Common Stock, par value $0.01 per share UNDERWRITING AGREEMENTUnderwriting Agreement • November 8th, 2017 • AMERI Holdings, Inc. • Semiconductors & related devices • New York
FORM OF UNDERWRITING AGREEMENT [ Ÿ ] Shares [ Ÿ ] Warrants to Purchase Shares1 Ameri Holdings, Inc. Common Stock, par value $0.01 per share UNDERWRITING AGREEMENTUnderwriting Agreement • November 6th, 2017 • AMERI Holdings, Inc. • Semiconductors & related devices • New York
